South & Central America Cranial Implants Market
South & Central America Cranial Implants Market is growing at a CAGR of 6.4% to reach US$ 194.20 Million by 2031 from US$ 118.67 Million in 2023 by Type, Material, End User.

Published On: Aug 2025

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South & Central America Cranial Implants Market

At 6.4% CAGR, South & Central America Cranial Implants Market is Projected to be Worth US$ 194.20 Million by 2031, says Business Market Insights

According to Business Market Insights research, the South & Central America cranial implants market was valued at US$ 118.67 million in 2023 and is expected to reach US$ 194.20 million by 2031, registering a CAGR of 6.4% from 2023 to 2031. Customized implants and advancements in 3D printing with incorporation of original multilayer technology are among the critical factors attributed to driving the South & Central America cranial implants market growth.

Customized implants are emerging as a significant trend in the cranial implant market, primarily due to advancements in 3D printing and imaging technologies. Traditional off-shelf implants often lack the precision necessary for an optimal fit, especially in complex cranial reconstructions. In contrast, customized implants are specifically designed to match a patient’s unique anatomy, which can improve surgical outcomes and reduce complications. 3D printing enables the creation of highly personalized implants based on detailed computed tomography (CT) scans or magnetic resonance imaging (MRI) images, allowing for precise shapes, sizes, and contours. This tailored approach minimizes the risk of implant displacement, infection, and poor bone integration, among others. Customized implants may also feature bioactive coatings that promote bone regeneration to optimize strength and flexibility. Further, integrating customized implants into clinical practice enhances surgical precision, shortens recovery times, and improves long-term outcomes, making this approach a vital trend in the evolving cranial implant market.

On the contrary, the risk of implant failure hampers the growth of South & Central America cranial implants market.

By type, the South & Central America cranial implants market is segmented into parietal, frontal, occipital, temporal, and sphenoid. The parietal held a 33.9% share of South & Central America cranial implants market share in 2023, amassing US$ 40.23 million. It is projected to garner US$ 67.96 million by 2031 to register 6.8% CAGR during 2023–2031.

In terms of material, the South & Central America cranial implants market is segmented into polymethyl methacrylate, polyether ether ketone, titanium, and others. The polyether ketone held a 39.6% share of South & Central America cranial implants market share in 2023, amassing US$ 52.92 million. It is projected to garner US$ 87.19 million by 2031 to register 6.4% CAGR during 2023–2031.

Based on end user, the South & Central America cranial implants market is segmented into hospitals, trauma centers, and others. The hospitals held a 60.2% share of South & Central America cranial implants market share in 2023, amassing US$ 71.43 million. It is projected to garner US$ 121.50 million by 2031 to register 6.9% CAGR during 2023–2031.

Based on country, the South & Central America cranial implants market is categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that Brazil captured 42.6% share of South & Central America cranial implants market in 2023. It was assessed at US$ 50.57 million in 2023 and is likely to hit US$ 85.10 million by 2031, registering a CAGR of 6.7% during 2023–2031.

Key players operating in the cranial implants market are Stryker Corp, Zimmer Biomet Holdings Inc, Integra LifeSciences Holdings Corp, OsteoMed SA, Anatomics Pty Ltd, Matrix Surgical Holdings LLC, Calavera Surgical, Medtronic Plc, Xilloc Medical BV, Johnson & Johnson, evonos GmbH & Co. KG, B Braun SE, UAB Ortho Baltic, 3D Systems Corp, GPC Medical Ltd, Bioplate Inc, EUROS SAS, Biocomposites Ltd, Medprin Biotech GmbH, Kelyniam Global Inc, MedCAD, KLS Martin Group, and Longeviti Neuro Solutions LLC, among others.

  • On April-2024: Kelyniam Global and Fin-ceramica, Faenza S.p.a., makers of custom cranial implants, announced the launch of the NEOS Surgery Cranial LOOP fixation system has received 510(k) clearance from the FDA for use with Finceramica's Customized Bone hydroxyapatite cranial implant.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com